FCM
IBB icon

Fortis Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Fortis Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,193
Closed -$2M – 118
2021
Q2 		$2M Buy
+12,193
New +$1.88M 1.01% 50

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Fortis Capital Management's IBB Position: Q3 2021 in Review

Fortis Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 12,193 shares — an estimated $2M sold.

Fortis Capital Management first reported a position in IBB in Q2 2021 and held it in 1 quarter. The position peaked at $2M in Q2 2021. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

  • Fortis Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
  • Fortis Capital Management sold 12,193 iShares Biotechnology ETF shares in Q3 2021, an estimated $2M.
  • Fortis Capital Management first reported a position in iShares Biotechnology ETF in Q2 2021 and held it in 1 quarter.
  • Fortis Capital Management's iShares Biotechnology ETF position peaked at $2M in Q2 2021.
  • 855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Fortis Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.